DEPLOYDatabase

Robot model

Pixel Watch

biometriccommercialby Google
$349verifiedas of Sep 2024

Pixel Watch (made by Google, part of Alphabet; current model the Pixel Watch 4 from October 9, 2025) is a biometric-primary smartwatch with cardiac AI…

Track Pixel Watch
Manufacturer
Google
Form factor
biometric
Maturity
commercial
Lifecycle
active
Deployments
2
Website
blog.google ↗

The verified answer

As of Sep 2026, DEPLOY verifies Pixel Watch, a biometric by Google (commercial): 2 verified deployments on record. 5 sources back the record.

Regulatory status2 FDA 510(k) clearances

Pixel Watch holds 2 FDA 510(k) clearances, per the DEPLOY registry.

See all 2 filings

Overview

Pixel Watch (made by Google, part of Alphabet; current model the Pixel Watch 4 from October 9, 2025) is a biometric-primary smartwatch with cardiac AI augmentation, recorded in the new biometric form factor under a new Google company entity, with its health stack running on Fitbit and Google Health algorithms since Google owns Fitbit. Its standout FDA clearance is Loss of Pulse Detection, cleared on February 26, 2025 as the first feature of its kind, which detects a loss-of-pulse event such as cardiac arrest, respiratory or circulatory failure, or overdose and automatically prompts a call to emergency services if the user is unresponsive, alongside the Fitbit-lineage ECG app cleared in 2020 and atrial-fibrillation notifications cleared in 2022 carried into the Pixel Watch.

A cap-flag applies because Loss of Pulse Detection is not a cardiac-monitoring or diagnostic feature and is explicitly excluded for users with preexisting heart conditions or those needing cardiac monitoring, with Google noting it may not detect every instance, so marketing it as general heart safety for cardiac patients exceeds the indication, and the cited 98.7-percent sensitivity and 100-percent specificity ECG figures are Google-reported algorithm performance. Fitbit, also Google-owned through its 2021 acquisition, is recorded as a separate registry entity, and the Fitbit app was rebranded to Google Health on May 7, 2026 with an optional $9.99-per-month premium tier gating a Gemini-powered AI coach.

Its clinical-validation posture is growing, anchored by the large Fitbit Heart Study and Google's own loss-of-pulse validation but with lower independent peer-review volume than Apple, and the exact loss-of-pulse FDA submission number and whether the Pixel Watch 4 adds net-new clearances beyond inherited features are not verified.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Form factor

biometric-primary smartwatch with cardiac AI augmentation

Current model

Pixel Watch 4 (October 9, 2025)

FDA clearance

Loss of Pulse Detection cleared February 26, 2025 (510(k) K242967)

ECG performance

98.7% sensitivity / 100% specificity (Google-reported)

Sensor suite

multipath PPG optical HR, ECG, SpO2, skin temperature, accelerometer; HRV, breathing rate, resting HR

Premium price

$9.99/month (Google Health Premium optional)

Price

Pixel Watch 4 from $399.99 (one-time purchase, no subscription required)

Pricing model

One-time hardware purchase + optional $9.99/month Google Health Premium

Availability

Commercial — Google Store, Best Buy, Amazon

Specs

Notes

FDA clearances: Loss of Pulse Detection: FDA-cleared Feb 26 2025 - FIRST-of-its-kind; detects a loss-of-pulse event (cardiac arrest, respiratory/circulatory failure, overdose) and auto-prompts a 911 call if the user is unresponsive. ECG app (Fitbit lineage, cleared 2020) + AFib/irregular-rhythm (Fitbit, 2022) carried into Pixel Watch., CAP-FLAG: Loss of Pulse Detection is NOT cardiac-monitoring/diagnostic and is EXPLICITLY excluded for users with preexisting heart conditions or needing cardiac monitoring ('may not detect every instance') - marketing it as general heart-safety for cardiac patients exceeds the indication. The ECG 98.7% sensitivity / 100% specificity figures are Google-reported algorithm performance (company-stated)., Entity note: Recorded under a new 'google' company (Alphabet; consumer Pixel hardware). Fitbit (also Google-owned, acquired 2021) is a SEPARATE registry entity. Fitbit app rebranded to Google Health (May 7 2026)., Verification posture: Boundary: biometric-primary + AI-augmented. Clinical posture: GROWING (Fitbit Heart Study ~455k participants; Loss-of-Pulse on Google's own validation; lower independent peer-review than Apple). NOT verified: exact FDA submission number for Loss of Pulse; whether PW4 adds net-new clearances beyond inherited PW3 features., Source/methodology (Phase 1A, 2026-06-04): Primary-FDA source added. Pathway cap-flag: Loss of Pulse Detection is on the FDA record as a 510(k) (K242967, substantially-equivalent), NOT a De Novo, though the loss-of-pulse DEVICE TYPE (product code SDY) was established via an earlier De Novo; some coverage frames it as De Novo. The accessdata 510(k) record is authoritative. Fitbit-lineage ECG/AFib on Pixel governed by K200948 (ECG) + K212372 (IRN).

Specs

Pixel Watch (current: Pixel Watch 4, Oct 9 2025; PW3 supported). Sensors: multipath PPG optical HR, ECG (crown + caseback), SpO2, skin temperature, accelerometer; HRV, breathing rate, resting HR. Health stack runs on Fitbit/Google Health algorithms (Google owns Fitbit). Hardware purchase; Google Health Premium $9.99/mo optional (gates Sleep Profile + Gemini AI coach).

Form Factor

biometric (biometric-primary smartwatch + AI augmentation; loss-of-pulse / cardiac AI)

Fda clearance

Source: fda.gov Status: cleared; Details: Pixel Watch 1/2: FDA-cleared ECG via Fitbit integration (same K203204). Fall detection. NOT cleared for blood glucose or blood pressure.; Audited at: 2026-06-07; Source name: FDA; Health claim: ECG + fall detection via Fitbit algorithms. Wellness/fitness primary with FDA-cleared cardiac feature.; Verification posture: verified

Data & sources

Government records

1

Web sources

4

5 sources backing this record.View all →

Availability and pricing

Availability
Shipping now
Price
$349 to $399 (actual sale price)as of 2024-09-10
Units in field
Not disclosed
Sales model
Not disclosed
Lead time
Not disclosed

Pricing

One-time purchase

$349 - $399 USDactual sale priceas of 2024-09-10

Source: Google Store (Pixel Watch)

Price status: actual-sale-price = real published price at time of sale; manufacturer-target = vendor target, not yet realized; analyst-estimate = third-party projection, not a vendor figure; not-announced = no price on record.

Prices verified as of Sep 10, 2024

Deployments (2)

Free to use on your site, with a link back to DEPLOY.

Pixel Watch on the deployment map

View the global map

Where Pixel Watch is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Manufacturer-attributed media (2)

Manufacturer-supplied media at the model level. Not tied to an independently verified named-site deployment. Verification posture is product-showcase from the maker, distinct from the deployment-verified evidence in the section above.

PRIMARY SOURCE
Courtesy of Google

Google's introduction of the Pixel Watch 2. Its ECG and Loss of Pulse Detection are FDA-cleared features; sleep and readiness metrics are wellness-grade.

Supply chain (1)

Compute / semiconductor

  • QualcommQualcomm Snapdragon W5+ Gen 1 Wearable Platform -- primary SoC in Pixel Watch 2 and Pixel Watch 3; 4nm process node, Cortex-A53 cluster, Adreno GPU, ultralow-power islandsupplies

Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.

Regulatory filings (2)

Safety record

No incidents on record for Pixel Watch.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (5)

  1. https://blog.google/feed/pixel-watch-3-loss-of-pulse-detection-fda/
  2. https://www.engadget.com/wearables/pixel-watch-3-receives-fda-clearance-for-loss-of-pulse-detection-210458883.html
  3. https://blog.google/intl/en-au/products/devices-services/pixel-watch-4-design-upgrades-new-fitness-features-and-expanded-ai/
  4. https://www.droid-life.com/2026/04/24/google-health-looking-like-fitbits-replacement/
  5. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K242967

Compare Pixel Watch

Common questions

What is Pixel Watch?
Pixel Watch (made by Google, part of Alphabet; current model the Pixel Watch 4 from October 9, 2025) is a biometric-primary smartwatch with cardiac AI augmentation, recorded in the new biometric form factor under a new Google company entity, with its health stack running on Fitbit and Google Health algorithms since Google owns Fitbit. Its standout FDA clearance is Loss of Pulse Detection, cleared on February 26, 2025 as the first feature of its kind, which detects a loss-of-pulse event such as cardiac arrest, respiratory or circulatory failure, or overdose and automatically prompts a call to emergency services if the user is unresponsive, alongside the Fitbit-lineage ECG app cleared in 2020 and atrial-fibrillation notifications cleared in 2022 carried into the Pixel Watch. A cap-flag applies because Loss of Pulse Detection is not a cardiac-monitoring or diagnostic feature and is explicitly excluded for users with preexisting heart conditions or those needing cardiac monitoring, with Google noting it may not detect every instance, so marketing it as general heart safety for cardiac patients exceeds the indication, and the cited 98.7-percent sensitivity and 100-percent specificity ECG figures are Google-reported algorithm performance. Fitbit, also Google-owned through its 2021 acquisition, is recorded as a separate registry entity, and the Fitbit app was rebranded to Google Health on May 7, 2026 with an optional $9.99-per-month premium tier gating a Gemini-powered AI coach. Its clinical-validation posture is growing, anchored by the large Fitbit Heart Study and Google's own loss-of-pulse validation but with lower independent peer-review volume than Apple, and the exact loss-of-pulse FDA submission number and whether the Pixel Watch 4 adds net-new clearances beyond inherited features are not verified.
How much does Pixel Watch cost?
Pixel Watch is listed at $349 to $399 on the DEPLOY registry. This is an actual sale price on record.
Google Store (Pixel Watch)
Is Pixel Watch actually deployed in the real world?
Yes. Pixel Watch is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Is Pixel Watch autonomous or teleoperated?
Partly. DEPLOY verifies Pixel Watch operating autonomously for Tracks fitness and activity. Other capabilities (Tracks sleep and Detects irregular heart rhythm) are only demonstrated under teleoperation or remain vendor claims, not independently verified as autonomous.
Who makes Pixel Watch?
Pixel Watch is made by Google, based in Mountain View, California, USA, founded in 1998.
Where is Pixel Watch deployed?
2 verified deployments of Pixel Watch are on the DEPLOY registry, including at United States (multiple hotel chains), Germany, Europe.
Can you buy Pixel Watch?
Pixel Watch is available for purchase - a real sale price is on record (see the pricing section for the figure and its source).
Is Pixel Watch FDA cleared?
Pixel Watch has 2 regulatory records on the DEPLOY registry: FDA 510(k) clearance (K242967), cleared; FDA 510(k) clearance (K242967), cleared. See the Regulatory filings section for each agency source.
What are alternatives to Pixel Watch?
On the DEPLOY registry, comparable biometric robots to Pixel Watch include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, RNS System.
How does Pixel Watch compare to Blackrock Neuroport Array?
Pixel Watch and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. Pixel Watch has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Pixel Watch a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Pixel Watch ranks in roughly the top 4% of biometric models tracked by the registry.
What is Pixel Watch's maturity stage?
Pixel Watch is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Pixel Watch safe?
Pixel Watch has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
What does the Google Pixel Watch track?
The Google Pixel Watch tracks sleep, fitness, activity, steps, calories, GPS data, and more. It integrates with Google Health for hands-free well-being tracking. Features include text, navigation, pay, and safety features. Pixel Watch has FDA-cleared ECG (510(k) K242967) and loss of pulse detection.
Google: Pixel Watch Google: Pixel Watch activity tracking
Methodology: Verified · 5 sources (1 primary) · last reviewed 2026-06-28

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-06-28

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

4
unclassified
Unclassified source
1
primary-fda-database
FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Pixel Watch.

Recent coverage

Pixel Watch in third-party press

The wearable future is stuck in weird, experimental, existential limbo

Aug 19, 2026

Google Pixel Watch 5 Review: More Health, More AI

Aug 19, 2026

We reviewed the new Pixel lineup, ask us anything

Aug 19, 2026